iPLEDGE and the System Reshaping Dermatology Access
In the landscape of American healthcare, few programs are as controversial—or as misunderstood—as iPLEDGE, the FDA-mandated risk-management system tied to isotretinoin, a powerful acne medication that transformed dermatology more than four decades ago. Within the first hundred words, the search intent becomes unmistakable: readers want to understand what iPLEDGE is, why it exists, how it…
